TMDX Q4 2018 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$4B

Q4 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$4M+68.3% YoY

Gross Profit

$1M42.3% margin

Operating Income

-$6M-179.5% margin

Net Income

-$8M-215.4% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

-12.3%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$52,000

Balance Sheet

Total Assets

$42M

Total Liabilities

$47M

Stockholders' Equity

-$5M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$2M	+68.3%
Gross Profit	$1M	$529,000	+183.4%
Operating Income	-$6M	-$5M	-41.2%
Net Income	-$8M	-$5M	-64.3%